Llwytho...
Methyl-CpG-binding protein 2 mediates antifibrotic effects in scleroderma fibroblasts
OBJECTIVE: Emerging evidence supports a role for epigenetic regulation in the pathogenesis of scleroderma (SSc). We aimed to assess the role of methyl-CpG-binding protein 2 (MeCP2), a key epigenetic regulator, in fibroblast activation and fibrosis in SSc. METHODS: Dermal fibroblasts were isolated fr...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Ann Rheum Dis |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7297461/ https://ncbi.nlm.nih.gov/pubmed/29760157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2018-213022 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|